FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

30763011000001103: Lymecycline 408mg capsules (Almus Pharmaceuticals Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 14-Oct 2015. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
94157201000001114 Lymecycline 408mg capsules (Almus Pharmaceuticals Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
94157301000001117 Lymecycline 408mg capsules (Almus Pharmaceuticals Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lymecycline 408mg capsules (Almus Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Lymecycline 408mg capsules (Almus Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Lymecycline 408mg capsules (Almus Pharmaceuticals Ltd) Is a Product containing precisely lymecycline 408 milligram/1 each conventional release oral capsule true Inferred relationship Existential restriction modifier
Lymecycline 408mg capsules (Almus Pharmaceuticals Ltd) Has active ingredient Lymecycline false Inferred relationship Existential restriction modifier
Lymecycline 408mg capsules (Almus Pharmaceuticals Ltd) Has manufactured dose form Conventional release oral capsule true Inferred relationship Existential restriction modifier
Lymecycline 408mg capsules (Almus Pharmaceuticals Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Lymecycline 408mg capsules (Almus Pharmaceuticals Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Lymecycline 408mg capsules (Almus Pharmaceuticals Ltd) Has specific active ingredient Lymecycline true Inferred relationship Existential restriction modifier
Lymecycline 408mg capsules (Almus Pharmaceuticals Ltd) Has dispensed dose form Capsule true Inferred relationship Existential restriction modifier
Lymecycline 408mg capsules (Almus Pharmaceuticals Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Lymecycline 408mg capsules (Almus Pharmaceuticals Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Lymecycline 408mg capsules (Almus Pharmaceuticals Ltd) 28 capsule Has AMP True Lymecycline 408mg capsules (Almus Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier
Lymecycline 408mg capsules (Almus Pharmaceuticals Ltd) 56 capsule Has AMP True Lymecycline 408mg capsules (Almus Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start